Semax
Approved in Russia, nowhere else. Most of the literature is in Russian and hard to appraise from outside.
Approved in some countries
| What it is | A synthetic analogue of a fragment of ACTH, developed in Russia. |
|---|---|
| How it is thought to work | Reported to raise BDNF and modulate the dopaminergic and serotonergic systems. |
| What the evidence actually shows | Used clinically in Russia for stroke and cognitive indications. Most published work is Russian-language, with limited independent replication and few trials meeting Western regulatory standards. |
| Regulatory status | Registered as a medicine in Russia. Not approved in the US, EU, UK or Canada. |
| Dosing | There is a Russian clinical dosing standard for the intranasal product. It is not an FDA-approved dose and the research-grade material is not that product. |
| In the catalog as |
Risks and cautions
- Limited independent safety data outside Russia.
- Interactions with psychiatric medication are not well characterised.
Sources
Before you act on any of this
This page describes what is known and what is not. It is not a recommendation to use anything, and it is not a protocol. Compounds listed as research chemicals are not approved medicines and are not sold for human use. Talk to a doctor who knows your history.